TKNO
Alpha Teknova, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.44
+1.40%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$7.44
From 52W high−20.22%
Volume8194.00
Market cap$459.26M
P/E (TTM)—
P/S (TTM)10.5x
Div yield—
Key dataNov 4, 2026
Open
$7.44
From 52W high
−20.22%
Volume
8194.00
Market cap
$459.26M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−49.6x
P/E (TTM)
—
RSI (14)
46.8
MomentumView details →
1D Return
+1.40%
YTD Return
+88.83%
SummaryUpdated Jun 1, 2026
Alpha Teknova, Inc. (NASDAQ:TKNO) is a California-based life sciences company founded in 1996 that provides critical reagents and laboratory consumables to the biotechnology and pharmaceutical industries. The company went public in June 2021 and is headquartered in Hollister, California. Alpha Teknova specializes in manufacturing high-quality reagents that enable the discovery, development, and production of biopharmaceutical products including drug therapies, vaccines, and molecular diagnostics.
Similar companies
Latest newsMore news →
Alpha Teknova, Inc. shares rose 5.1% in the last session on higher-than-average trading volume.12d agoAlpha Teknova, Inc. announced that it will report financial results for the third quarter ended September 30, 2026, after market close on November 4, 2026.14d agoAlpha Teknova announced preliminary unaudited financial results for the three months ended September 30, 2026.15d ago